MedTrace Logo

Community Enhanced Virtual Informed Consent

NCT07805083 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2026-09-04

No results posted yet for this study

Summary

The goal of this clinical trial is to examine perceptions of virtual human communicators and cancer research recruitment messages. This study will also examine how different informed consent approaches influence decisions to participate in research.

Conditions

  • Hematopoietic and Lymphatic System Neoplasm
  • Malignant Solid Neoplasm

Interventions

BEHAVIORAL

Behavioral Intervention

View cancer messaging

OTHER

ICF Text Version 1

Receive a text-based informed consent form

OTHER

ICF Text Version 2

Receive an adapted text-based informed consent form

OTHER

ICF Video Version 1

Receive a video-based informed consent form delivered by virtual human #1

OTHER

ICF Video Version 2

Receive a video-based informed consent form delivered by virtual human #2

OTHER

ICF Video Version 3

Receive a video-based informed consent form delivered by virtual human #3

OTHER

ICF Video Version 4

Receive a video-based informed consent form delivered by virtual human #4

OTHER

Survey Administration

Ancillary studies

Sponsors & Collaborators

Principal Investigators

  • Janice L. Krieger, PhD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-21
Primary Completion
2027-07-20
Completion
2029-07-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07805083 on ClinicalTrials.gov